Covaxin Phase 3 Trial Data In July; 100% Effective Against Hospitalisations; Phase 4 Next
Photo: Republicworld

Covaxin Phase 3 Trial Data In July; 100% Effective Against Hospitalisations; Phase 4 Next

Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial, will publish the data in July, and following that the company will be applying for the full licensure for Covaxin. Speaking about Covaxin's efficacy, Bharat Biotech said that the efficacy data of… Read More

Visit www.werindia.com OR Hindi.werindia.com to read news from 500+ news sources... आपका अपना डिजिटल अख़बार |

Leave a Reply


After US, Bharat Biotech to Manufacture Covaxin in Canada
Photo: India

After US, Bharat Biotech to Manufacture Covaxin in Canada

Hyderabad: India’s first indigenous COVID-19 vaccine ‘Covaxin’ will now be sold and manufactured in Canada as Bharat Biotech has extended its tie-up with biopharmaceutical company Ocugen Inc to expand to the Canadian market after the US. Bharat Biotech will have exclusive co-development, manufacturing, and commercialisation rights… Read More

Visit www.werindia.com OR Hindi.werindia.com to read news from 500+ news sources... आपका अपना डिजिटल अख़बार |

Leave a Reply


COVAXIN Trials On Children Aged 2-18 Begin At AIIMS, Patna
Photo: in.finance

COVAXIN Trials On Children Aged 2-18 Begin At AIIMS, Patna

The All India Institute of Medical Sciences (AIIMS) in Patna has begun the clinical trials for COVAXIN on children, reports say. COVAXIN is India's only approved homemade anti-coronavirus vaccine so far, developed by the Hyderabad-based firm Bharat Biotech. The development holds significance as there is… Read More

Visit www.werindia.com OR Hindi.werindia.com to read news from 500+ news sources... आपका अपना डिजिटल अख़बार |

Leave a Reply


Centre Takes Steps To Accelerate Domestic Vaccine Production
Photo: pib.gov

Centre Takes Steps To Accelerate Domestic Vaccine Production

Haffkine Biopharma to produce 22.8 crore doses per annum of Covaxin under technology transfer arrangement with Bharat Biotech, With the aim of vaccinating the entire eligible population at the earliest, domestic vaccine production is being steadily ramped up in the country with help from the… Read More

Visit www.werindia.com OR Hindi.werindia.com to read news from 500+ news sources... आपका अपना डिजिटल अख़बार |

Leave a Reply


Bharat Biotech’s Covaxin Shows 78 Percent Efficacy In Phase 3 Analysis
Photo: Swarajyamag

Bharat Biotech’s Covaxin Shows 78 Percent Efficacy In Phase 3 Analysis

The final phase 3 analysis of Covaxin, the Covid-19 jab developed by Bharat Biotech, has shown the efficacy of 78 per cent in preventing symptomatic coronavirus caused disease, a report said. . Read more at: https://swarajyamag.com/news-brief/bharat-biotechs-covaxin-shows-78-percent-efficacy-in-phase-3-analysis . Read More

Visit www.werindia.com OR Hindi.werindia.com to read news from 500+ news sources... आपका अपना डिजिटल अख़बार |

Leave a Reply


India's COVAXIN Vaccine Gets Authorisation In 13 Nations; working On EUAs In 60 More + WHO
Photo: Republicworld

India’s COVAXIN Vaccine Gets Authorisation In 13 Nations; working On EUAs In 60 More + WHO

Bharat Biotech's COVAXIN has made a massive leap into the global market as it announced that it has obtained the Emergency Use Authorization in 13 countries While India continues to expedite COVID-19 vaccine production with an aim to provide on-demand jabs by August this year,… Read More

Visit www.werindia.com OR Hindi.werindia.com to read news from 500+ news sources... आपका अपना डिजिटल अख़बार |

Leave a Reply